Skip to content

Driving Life Science Innovation 

orangeline3

Through Human Language

Machine Learning Solutions
Made with, by, and for
Life Science Professionals

 

Who We Are

Executive
Team

Meet the founders 
of Huma.AI

Advisory
Board

Standing on the 
shoulders of giants

Huma.AI
Investors

Backed by forward thinkers

Executive Team

Untitled design-8

Lana Feng, Ph.D.

Co-founder and CEO

Dr. Feng has over 20 years of experience in the biotech and pharmaceutical industries, mostly in precision medicine.

Previously, she worked with Novartis Oncology Business Unit to establish international partnerships for their precision medicine programs. She joined Novartis through its acquisition of Genoptix. Dr. Feng built the BioPharma division at Genoptix.

She grew the business from zero to $45M in five years by forging alliances with pharmaceutical companies and providing CDx development for targeted therapies.

Untitled design-9

Greg Kostello

Co-founder and CTO

Greg Kostello has dedicated his more than 35-year career to architecting and managing technology systems that solve complex data and business problems.

Previously, Kostello was the CEO for the SaaS Platform used by Cisco, ESPN, and NASA, managing petabytes of data. He also worked with video enabling technology at three startups, one acquired by Facebook, EVP of Technology at MP3.com, was President of VUNet Technologies, founded a startup acquired by Netscape, and team-built the core engine for Firefox.

His experience also includes contributions at Apple Computer, and he is the author of Huma.AI’s granted NLP patent with 25 claims.

misty website round

Misty Burkhart

Vice President, US Sales

Misty Burkhart is a veteran sales executive with a solid background in the pharmaceutical and healthcare industry. Her expertise is in strategic negotiations, sales, digital technology, direct marketing, and data-driven methods. Misty has a track record of consistent success.
 
Before joining Huma.AI, she had prominent sales positions with Clarivate, a leading provider of information services. There, Misty was appointed Global Head of Analytics, where she supervised a team of data and analytics services personnel in the pharmaceutical, biotechnology, and healthcare fields. Misty earned her BBS degree from Hardin-Simmons University with an emphasis on Communication and Biology.
Anne Licata Website Round

Anne LiCata

Vice President, Customer Success

Prior to joining Huma.AI, Anne was a Senior Product Solutions Manager at Innoplexus, a data and analytics company that integrates AI, machine learning, and blockchain technology in life sciences.
 
Most recently, Anne served as the Global Lead of Training and Enablement for Customer Success as well as Director of Customer Success at Clarivate/DRG. Anne also was at Informa Pharma Intelligence as a Relationship Manager in the inaugural season of the Platinum Partnership Program, where she offered top-notch support for all Informa solutions, including Citeline, Datamoritor, BioMedTracker and their pharma publications, Scrip, The Pink Sheet and InVivo.

Advisory Board

Bassil Akra, Ph.D.

Untitled design-16

CEO, Akra Team GMBH 

  • Former VP, TÜV SÜD Product Service GmbH

  • EU MDR and IVDR Advisor

  • Editor of "The Post-Market Gambit"

 Yusung Chang, Ph.D

Untitled design-11

Co-founder, Huma.AI

  • 15+ years in AI: compute vision & data visualization.

  • Head of Product at Wolfram Alpha

  • Co-founder of Huma.AI

Karen Drexler

Untitled design-12

Corporate Board Director, 
ResMed & Outset Medical

  • Executive Committee - Springboard

  • CEO, Amira Medical (acquired by Roche Diagnostics)

J-O Racine

J-O Racine headshot

CTO, Outset Medical 

  • Transforming dialysis with Machine Learning

  • Former Head of Engineering & Science at AWS Health AI

  • 20+ years in Enterprise IT

Huma.AI Investors

Huma.AI is a venture-backed AI startup based in Seattle that was co-founded in 2018 by CEO Lana Feng, Ph.D., and CTO Greg Kostello, to bridge the gap between scientific data and life science decision making.

The Series A funding was led by Excelerate Health Ventures with participation from Hatteras Venture Partners, Boston Millennia Partners, SteelSky Ventures, W Fund, King Fund, and Human Longevity Venture Fund. Current Huma.AI investors Fusion Fund and ShangBay Capital also participated.

Logo1-Excel-1
Logo1-Fusion
Logo1-Hat
Logo1-Human-1
Logo1-Mil-2
Logo1-shang-3
Logo1-Steel-1
Logo1-W-1-1

Your Machine Learning Technology Partner for Driving Life Science Innovation.

Request a Demo of Huma.AI